Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Litigation Capital Management Limited LSE:LIT London Ordinary Share AU000000LCA6 ORD NPV (DI)
  Price Change % Change Share Price Shares Traded Last Trade
  0.25 0.23% 108.50 654,570 16:35:22
Bid Price Offer Price High Price Low Price Open Price
108.00 109.00 110.00 106.00 108.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 28.93 6.50 4.05 29.8 118
Last Trade Time Trade Type Trade Size Trade Price Currency
16:30:09 O 50,000 109.00 GBX

Litigation Capital Manag... (LIT) Latest News

More Litigation Capital Manag... News
Litigation Capital Manag... Investors    Litigation Capital Manag... Takeover Rumours

Litigation Capital Manag... (LIT) Discussions and Chat

Litigation Capital Manag... Forums and Chat

Date Time Title Posts
23/7/202117:35A newer, freer thread but only for honest posters.516
13/7/202115:31LIT120
28/6/202118:11:: LITIGATION CAPITAL MANAGEMENT1,185
25/5/202113:5450% growth year after year after year46
19/12/201809:56Litcomp 50% growth, year after year after year5

Add a New Thread

Litigation Capital Manag... (LIT) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
16:30:10109.0050,00054,500.00O
16:17:46109.3250,00054,662.00O
15:29:10109.002,0002,180.00AT
15:29:09109.002,2562,459.04AT
15:29:09109.002,0002,180.00AT
View all Litigation Capital Manag... trades in real-time

Litigation Capital Manag... (LIT) Top Chat Posts

DateSubject
23/7/2021
09:20
Litigation Capital Manag... Daily Update: Litigation Capital Management Limited is listed in the General Financial sector of the London Stock Exchange with ticker LIT. The last closing price for Litigation Capital Manag... was 108.25p.
Litigation Capital Management Limited has a 4 week average price of 106p and a 12 week average price of 88.60p.
The 1 year high share price is 138.50p while the 1 year low share price is currently 54.20p.
There are currently 108,687,929 shares in issue and the average daily traded volume is 330,893 shares. The market capitalisation of Litigation Capital Management Limited is £117,926,402.97.
23/7/2021
17:26
74tom: Yes I went looking for updated info on the Miton Value Opportunities fund 3 / The Diverse Income Trust, where LIT is held, however they haven't posted their accounts to 30th May yet. At of Feb 11th the Diverse Income trust held 3,456,573 shares which means that the value opportunities fund had to hold the remainder (2,045,077) to total 5,501,650. Both of these amounts are large enough to put the share price in reverse if being sold at best in the market, as opposed to another II. It's pleasing to see 600k volume today and there share price retaining the 1.08 support, hopefully not too much further to go until they are gone forever.
14/7/2021
08:14
someuwin: Excellent new article. Simon Thompson increases LIT target again. From 140p to 150p Bargain shares: Backing litigation funding winners A litigation funding company has announced three major litigation finance agreements in the past seven weeks and is set to launch a follow-on third-party fund... https://www.investorschronicle.co.uk/ideas/2021/07/13/bargain-shares-backing-litigation-funding-winners/
07/7/2021
09:12
djderry: greenknight1 and pete_bane,you both use similar sentence structure, grammar and call people names in the hope of belittling their views,so I'll deal with your points together. I am not attacking LIT's accounting methods.I am pointing out that both Bur and LIT use different methodologies and neither is perfect.My point is that to claim one is superior to another,with no evidence to substantiate your view is just,well,an opinion. Putting out an RNS ,for the reasons I have already outlined in detail stands.Calling a poster names will not change that.Putting money into a case has a range of outcomes.What don't you understand about that? It's akin to a gambler at the roulette wheel announcing they have placed a bet on black. The comment regarding fair value warrants further consideration .If a criticism can be made,it could well be the one you make,ie,that because Bur is so conservative about its fair-valuing,that it could mislead an investor as to the subsequent outcome.I think if you look at their track record,it's very much no fair value increase ( apart from Petersen,sparked by secondary sales) until the final year or two,then ,on average,30% of the eventual realisation.If you are one who likes one's company to underpromise and overdeliver,then I'm happy enough with it. To the poster who suggested I've lost a lot of money,I think you are mixing up volatility ( share prices going up and down ) with risk ( ie,losing one's money).I haven't lost a penny.I have continued to purchase Burford shares.I am not advising anyone else to do so.But I have not lost a penny.I still have the shares ( and,as an aside, received almost €6000 euro in dividends recently).You see,as an investor,I'm a part owner of the company.I know what I've bought and why I've bought them. If you want to improve as investors I would be happy to suggest some books as a primer.If you are confused about volatility and risk,I would recommend 'Thinking in bets' by Annie Duke. Finally,try to act like adults.Stop the name-calling.Most of us grew out of it when we were in short pants.
07/7/2021
07:21
djderry: And another thing,or two.This notion that an investment in a case is worthy of an RNS because it may materially affect the company is pretty far fetched.As with all single litigation matters,it is binary.It may be won,or lost,or settled with a range of outcomes.It may be 'a home run' or,an unmitigated disaster.And that warrants an RNS? So,from now on,when an employee shows up for work,we might expect an RNS? The truth is,we will only know the true outcome over time,perhaps years,perhaps much longer.( We all know the ' average' duration of cases but,on an individual matter,there is no such thing.) ( Not that I would encourage it,but if they were announcing a large portfolio financing arrangement,one might make a case for it warranting some kind of announcement,but hardly an RNS). Secondly,some poster alluded to the 'clean' accounting practices of LIT compared to Bur.You are wrong.Bur fair values and has never ( less than 1%)had to write down matters subsequently.In other words,they invariably underestimate their subsequent realised gains,to a substantial degree! Bur takes its expenses through the P and L, whereas LIT treats its litigation as a fixed contract ( with a static value) and capitalises its expenses,so we are left totally in the dark and you say that's ' clean' or somehow superior? I don't think so. So,to end,I began by making the point,LIT should not be announcing investments as an RNS.My point stands,for the reasons I have outlined. As an investor in LIT,I would welcome an announcement when the case comes to fruition,if it is material.
06/7/2021
20:23
someuwin: William Panlilio joins Litigation Capital Management (LCM) in Singapore July 6, 2021 Announcement, Commercial, Public Litigation Capital Management Limited, a global provider of disputes funding, publicly listed on the London Stock Exchange’s AIM market, is pleased to announce the hire of William Panlilio as an Investment Manager based in Singapore. With extensive experience in international arbitration and cross-border disputes, William joins LCM after more than five years with King & Spalding where he was part of that firm’s Trial and Global Disputes practice, operating in the energy, infrastructure, construction, technology and mining sectors, and conducting arbitrations involving States and State-owned or affiliated entities. Prior to that, William was an Assistant Legal Counsel at the Permanent Court of Arbitration in The Hague, The Netherlands for close to two years. While at the court, he assisted arbitral tribunals in treaty and commercial arbitrations involving various combinations of States, State entities, international organisations and private parties. William is a US qualified lawyer who started his career Orrick, Herrington & Sutcliffe in New York, specialising in complex commercial litigation, financial institutions litigation, and cases involving U.S. foreign relations law, including the Alien Tort Statute. Commenting on William’s hire, LCM’s Head of Investments (APAC), Susanna Taylor said: “We are very pleased to welcome William to the LCM team. He is a highly experienced practitioner with an impressive track record of commercial and treaty arbitrations as well as broader corporate and commercial expertise. We are experiencing a significant uptick in funding applications in the APAC region, particularly those originated from Singapore, and William is well placed to assist LCM to take advantage of the recent changes in Singapore to allow litigation funding for domestic arbitration and International Commercial Court claims. William is a valuable addition to our global team of high-performing investment managers”. Litigation Capital Management (LCM) is a leading international provider of dispute financing solutions. This includes single-cases and corporate and law firm portfolios across international arbitration, commercial claims, class actions and claims arising out of insolvency, including assignments. LCM has an unparalleled track record, driven by effective project selection and robust risk management. Headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.
06/7/2021
11:17
djderry: I'm not prepared to post under a header titled ' a newer freer (??) thread only for honest posters' so this will have to do.As an aside,I have all the idiots filtered but not the investors.You know who you are.As usual,all the caveats apply.I don't have a monopoly on wisdom,the shareprice tells you next to nothing about a company,etc,etc. I hold a 'watching brief' in LIT (single digit tens of thousands) and the share price is up 79%.I invested originally because I like the asset class and would have originally invested in Juridica.My core holding is Burford.My rationale for holding LIT is that,mostly,they seem to be following the Bur playbook and their UK branch is headed by a former Bur guy.They are much smaller and so one might speculate that some really good results could really move the needle. But it's more of a punt than an investment.Their cost of capital is quite high and the investment portfolio ,compared to Bur,is tiny.This notion of announcing investments in cases through an RSN is fairly bizarre.Imagine a footballer announcing ' I'm going to kick a ball.'As the Bard would say,' full of sound and fury,signifying nothing.As an investor,I need to be able to measure the metrics.They are revealed in the full year and interim results.I need to test their due diligence capacity and that can only be seen in the outcome to the cases.Of course,deployments can be seen as a proxy.But,unless I can get a sense of how the deployments are going ( as I can with Bur when I dig into their fair value gains,) LIT will have to remain in the ' watching brief' portfolio.
21/6/2021
14:01
adamb1978: Hi Maddox That's a fair question. A company which can generate a 90% IRR or whatever it is and make a 2.35x turn on every $ invest should be rated extremely highly. They've historically traded on a P/NAV of around 2x, which isnt massively generous compared to those returns. I dont think the market really knows how to value LIT. I think LIT will need to further prove that they can generate the returns which they state over a longer period of time and perhaps then as the NAV swells the share price will skew up appropriately. Maybe they'll even begin to pay out a very high, regular yield or ongoing special divis and that will bring in a new range of investors? Either way I think as long as the business keeps performing, the value should gradually come through. Adam
21/6/2021
11:18
maddox: Hi AdamB1978, I tend to think that LIT should be valued on a multiple of it's invested capital. Question is, when you can generate a return of 2.35x (long-term track record) what value would you put on LIT? Back of the envelope calc. LIT has c.£92m invested; LIT's current mkt cap of £127m, so LIT is currently valued at c. 1.35x its invested capital. Regards Maddox
27/4/2021
08:42
74tom: Agreed, I laughed when he turned up with shades & a fake afro, but the quality of the content was excellent. @Jamesmith, I think you underestimate how challenging it is for most people to undertake proper research themselves. For one thing it takes a lot of time & secondly you have to know what you are looking for. Eg. it's not enough to look at LIT in isolation, you need to contextualise the investment case vs Peers (Omni Bridgeway was very useful to see how the Asset Management business can grow), and also be aware of the path that BUR followed. That's more than the majority can be bothered to read! I agree that the principle of blindly following is dangerous though, you just need to look at the Vox Markets Podcast to see how dodgy some of it is. From my experience, the good promoters talk about market cap ahead of share price, the shysters focus entirely on the share price...
16/3/2021
13:45
parob: Litigation Capital Management: Patrick Moloney, CEO, gives an overview of LIT's H1 21 results and what to expect looking forward.Video: hTTps://www.piworld.co.uk/2021/03/16/litigation-capital-management-lit-interim-results-2021-overview/Podcast: hTTps://piworld.podbean.com/e/litigation-capital-management-lit-interim-results-2021-overview/
Litigation Capital Manag... share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
LIT
Litigation..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210723 19:02:03